Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state.
The increasing use of immunochromatography-based cassette kits or test strips is estimated to be one of the primary growth drivers for the global immunoprotein diagnostic testing market till 2023. Immunochromatography is the chromatographic method of immunoassay. It follows the lateral flow testing. It helps in the detection of infectious diseases, oncology, and autoimmune diseases using immunoproteins. The principle behind the working of immunochromatography is similar to the enzyme-linked immunosorbent assay (ELISA) test. These tests and reagents will improve the efficiency of diagnosis of diseases. Furthermore, several companies are investing heavily in research and developmental activities to develop products that reduce the time required to generate results.

Market Analysis and Insights: Global Immunoprotein Diagnostic Testing Market
The global Immunoprotein Diagnostic Testing market size is projected to reach US$ 24200 million by 2027, from US$ 15690 million in 2020, at a CAGR of 5.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunoprotein Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunoprotein Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunoprotein Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunoprotein Diagnostic Testing market.

Global Immunoprotein Diagnostic Testing Scope and Market Size
Immunoprotein Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunoprotein Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Prealbumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others

Segment by Application
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Beckman Coulter
DiaSorin
F. Hoffmann-La Roche
Siemens Healthineers